vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Forward Industries, Inc. (FWDI). Click either name above to swap in a different company.
Forward Industries, Inc. is the larger business by last-quarter revenue ($21.4M vs $21.2M, roughly 1.0× Autolus Therapeutics plc). Autolus Therapeutics plc runs the higher net margin — -373.3% vs -2732.2%, a 2358.9% gap on every dollar of revenue.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Melrose Industries plc is a British aerospace manufacturing company based in Birmingham, England. It is the parent company of GKN Aerospace. The company's shares are listed on the London Stock Exchange as a constituent of the FTSE 100 Index.
AUTL vs FWDI — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $21.4M |
| Net Profit | $-79.1M | $-585.7M |
| Gross Margin | — | 78.6% |
| Operating Margin | -337.9% | -2722.8% |
| Net Margin | -373.3% | -2732.2% |
| Revenue YoY | — | 224.0% |
| Net Profit YoY | 3.6% | -82611.5% |
| EPS (diluted) | $-0.30 | $-5.91 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $21.4M | ||
| Q3 25 | $21.2M | $7.9M | ||
| Q2 25 | $20.9M | $2.5M | ||
| Q1 25 | $9.0M | $3.1M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | $7.8M | ||
| Q1 24 | $10.1M | $5.1M |
| Q4 25 | — | $-585.7M | ||
| Q3 25 | $-79.1M | $-164.0M | ||
| Q2 25 | $-47.9M | $-850.0K | ||
| Q1 25 | $-70.2M | $-1.5M | ||
| Q4 24 | — | $-708.1K | ||
| Q3 24 | $-82.1M | — | ||
| Q2 24 | $-58.3M | $-399.6K | ||
| Q1 24 | $-52.7M | $-553.2K |
| Q4 25 | — | 78.6% | ||
| Q3 25 | — | 61.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -5.7% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 16.8% | ||
| Q1 24 | — | 26.2% |
| Q4 25 | — | -2722.8% | ||
| Q3 25 | -337.9% | -39.2% | ||
| Q2 25 | -292.6% | -102.6% | ||
| Q1 25 | -726.3% | -58.3% | ||
| Q4 24 | — | -13.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -5.9% | ||
| Q1 24 | -384.1% | -12.2% |
| Q4 25 | — | -2732.2% | ||
| Q3 25 | -373.3% | -2063.6% | ||
| Q2 25 | -229.0% | -34.1% | ||
| Q1 25 | -781.1% | -46.5% | ||
| Q4 24 | — | -10.7% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -5.1% | ||
| Q1 24 | -522.1% | -10.9% |
| Q4 25 | — | $-5.91 | ||
| Q3 25 | $-0.30 | $-21.86 | ||
| Q2 25 | $-0.18 | $-0.77 | ||
| Q1 25 | $-0.26 | $-1.32 | ||
| Q4 24 | — | $-0.64 | ||
| Q3 24 | $-0.31 | — | ||
| Q2 24 | $-0.22 | $-0.36 | ||
| Q1 24 | $-0.24 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $880.9M |
| Total Assets | $661.9M | $892.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $86.1M | — | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $880.9M | ||
| Q3 25 | $265.5M | $1.5B | ||
| Q2 25 | $346.5M | $3.4M | ||
| Q1 25 | $371.1M | $3.6M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | $477.0M | — | ||
| Q2 24 | $527.8M | $1.4M | ||
| Q1 24 | $582.0M | $1.8M |
| Q4 25 | — | $892.9M | ||
| Q3 25 | $661.9M | $1.5B | ||
| Q2 25 | $721.0M | $8.3M | ||
| Q1 25 | $746.3M | $12.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $827.5M | — | ||
| Q2 24 | $853.6M | $15.2M | ||
| Q1 24 | $901.4M | $15.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $-7.9M |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-7.9M | ||
| Q3 25 | $-67.9M | $-4.5M | ||
| Q2 25 | $-72.8M | $-1.2M | ||
| Q1 25 | $-75.6M | $-537.6K | ||
| Q4 24 | — | $-434.3K | ||
| Q3 24 | $-76.7M | — | ||
| Q2 24 | $-51.1M | $436.0K | ||
| Q1 24 | $-40.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-72.3M | $-4.5M | ||
| Q2 25 | $-80.1M | $-1.2M | ||
| Q1 25 | $-83.8M | $-539.0K | ||
| Q4 24 | — | $-439.7K | ||
| Q3 24 | $-86.3M | — | ||
| Q2 24 | $-51.9M | $426.8K | ||
| Q1 24 | $-41.0M | — |
| Q4 25 | — | — | ||
| Q3 25 | -341.2% | -57.0% | ||
| Q2 25 | -382.6% | -50.0% | ||
| Q1 25 | -933.1% | -17.3% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.5% | ||
| Q1 24 | -406.8% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 20.8% | 0.3% | ||
| Q2 25 | 34.8% | 0.8% | ||
| Q1 25 | 91.8% | 0.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | 5.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
FWDI
| CODM | $17.4M | 81% |
| Design Segment | $4.1M | 19% |
